PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Nanoparticle-Delivered IRF5 siRNA Facilitates M1 to M2 Transition, Reduces Demyelination and Neurofilament Loss, and Promotes Functional Recovery After Spinal Cord Injury in Mice.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27435985 ↗2016Reported benefit

Nanoparticle-Delivered IRF5 siRNA Facilitates M1 to M2 Transition, Reduces Demyelination and Neurofilament Loss, and Promotes Functional Recovery After Spinal Cord Injury in Mice.

MouseSpinal cord injuryUnspecifiedLipidoid nanoparticle delivery to macrophages infiltrating the injury siteAfter spinal cord injury; macrophages isolated from the epicentre at day 3 were…

Model: Experimental spinal cord injury in mice

IRF5 rose from day 1, peaked at day 7 and fell thereafter, mirroring CD86. Nanoparticle delivery of IRF5 siRNA markedly reduced M1 and increased M2 macrophages in the wound, resolved inflammation, attenuated demyelination and neurofilament loss, and significantly improved locomotor function (p < 0.…

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.